Good for what ails a stock portfolio. CVS reached nine-figure territory with that quarter's revenue, which came in slightly ...

Earlier this year, CVS Health shares fell after reports that Medicare payment rates would only increase by 0.09% next year. However, with Medicare's final ruling selecting a much higher 2.5% ...

Pharmacy retailer CVS Health (NYSE: CVS) is coming off an impressive bounce-back year in 2025 when its share price soared by 77%. A year earlier, it looked as if it was in an endless tailspin, falling ...

CVS Health (NYSE: CVS) has taken its shareholders on a tumultuous ride over the past five years. While the stock is up around 7% during that time frame, there were times when it was looking as if the ...

Looking ahead to 2030, our model projects CVS could trade at an average price of $189.41, with a potential range between $142.06 and $236.76. This represents a potential 109.2% return from today's ...

The stock trades at just 11 times earnings estimates for the next 12 months, much cheaper than rivals UnitedHealth and Humana ...

The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...

CVS Health has been a volatile investment to own in recent years, skyrocketing in 2025 after crashing in 2024. Rising costs have been weighing on investors' minds, but CVS has been doing better than ...